Spontaneous In Vivo Chondrogenesis of Bone Marrow‐Derived Mesenchymal Progenitor Cells by Blocking Vascular Endothelial Growth Factor Signaling
This study assessed whether simple inhibition of angiogenesis by vascular endothelial growth factor (VEGF) blockade is sufficient to direct in vivo chondrogenic differentiation of implanted human mesenchymal stromal/stem cells (MSCs). MSCs transduced to express sFlk‐1 and directly implanted subcutan...
Saved in:
Published in | Stem cells translational medicine Vol. 5; no. 12; pp. 1730 - 1738 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Durham, NC, USA
AlphaMed Press
01.12.2016
Oxford University Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | This study assessed whether simple inhibition of angiogenesis by vascular endothelial growth factor (VEGF) blockade is sufficient to direct in vivo chondrogenic differentiation of implanted human mesenchymal stromal/stem cells (MSCs). MSCs transduced to express sFlk‐1 and directly implanted subcutaneously in nude mice without in vitro preculture spontaneously differentiated into the chondrocytic lineage with a stable phenotype for the observation time‐period of 12 weeks. These findings suggest that VEGF blockade is a robust strategy to enhance cartilage repair by endogenous or grafted mesenchymal progenitors.
Acknowledgements
Chondrogenic differentiation of bone marrow‐derived mesenchymal stromal/stem cells (MSCs) can be induced by presenting morphogenetic factors or soluble signals but typically suffers from limited efficiency, reproducibility across primary batches, and maintenance of phenotypic stability. Considering the avascular and hypoxic milieu of articular cartilage, we hypothesized that sole inhibition of angiogenesis can provide physiological cues to direct in vivo differentiation of uncommitted MSCs to stable cartilage formation. Human MSCs were retrovirally transduced to express a decoy soluble vascular endothelial growth factor (VEGF) receptor‐2 (sFlk1), which efficiently sequesters endogenous VEGF in vivo, seeded on collagen sponges and immediately implanted ectopically in nude mice. Although naïve cells formed vascularized fibrous tissue, sFlk1‐MSCs abolished vascular ingrowth into engineered constructs, which efficiently and reproducibly developed into hyaline cartilage. The generated cartilage was phenotypically stable and showed no sign of hypertrophic evolution up to 12 weeks. In vitro analyses indicated that spontaneous chondrogenic differentiation by blockade of angiogenesis was related to the generation of a hypoxic environment, in turn activating the transforming growth factor‐β pathway. These findings suggest that VEGF blockade is a robust strategy to enhance cartilage repair by endogenous or grafted mesenchymal progenitors. This article outlines the general paradigm of controlling the fate of implanted stem/progenitor cells by engineering their ability to establish specific microenvironmental conditions rather than directly providing individual morphogenic cues.
Chondrogenic differentiation of mesenchymal stromal/stem cells (MSCs) is typically targeted by morphogen delivery, which is often associated with limited efficiency, stability, and robustness. This article proposes a strategy to engineer MSCs with the capacity to establish specific microenvironmental conditions, supporting their own targeted differentiation program. Sole blockade of angiogenesis mediated by transduction for sFlk‐1, without delivery of additional morphogens, is sufficient for inducing MSC chondrogenic differentiation. The findings represent a relevant step forward in the field because the method allowed reducing interdonor variability in MSC differentiation efficiency and, importantly, onset of a stable, nonhypertrophic chondrocyte phenotype. |
---|---|
AbstractList | Abstract
Chondrogenic differentiation of bone marrow-derived mesenchymal stromal/stem cells (MSCs) can be induced by presenting morphogenetic factors or soluble signals but typically suffers from limited efficiency, reproducibility across primary batches, and maintenance of phenotypic stability. Considering the avascular and hypoxic milieu of articular cartilage, we hypothesized that sole inhibition of angiogenesis can provide physiological cues to direct in vivo differentiation of uncommitted MSCs to stable cartilage formation. Human MSCs were retrovirally transduced to express a decoy soluble vascular endothelial growth factor (VEGF) receptor-2 (sFlk1), which efficiently sequesters endogenous VEGF in vivo, seeded on collagen sponges and immediately implanted ectopically in nude mice. Although naïve cells formed vascularized fibrous tissue, sFlk1-MSCs abolished vascular ingrowth into engineered constructs, which efficiently and reproducibly developed into hyaline cartilage. The generated cartilage was phenotypically stable and showed no sign of hypertrophic evolution up to 12 weeks. In vitro analyses indicated that spontaneous chondrogenic differentiation by blockade of angiogenesis was related to the generation of a hypoxic environment, in turn activating the transforming growth factor-β pathway. These findings suggest that VEGF blockade is a robust strategy to enhance cartilage repair by endogenous or grafted mesenchymal progenitors. This article outlines the general paradigm of controlling the fate of implanted stem/progenitor cells by engineering their ability to establish specific microenvironmental conditions rather than directly providing individual morphogenic cues.
Significance
Chondrogenic differentiation of mesenchymal stromal/stem cells (MSCs) is typically targeted by morphogen delivery, which is often associated with limited efficiency, stability, and robustness. This article proposes a strategy to engineer MSCs with the capacity to establish specific microenvironmental conditions, supporting their own targeted differentiation program. Sole blockade of angiogenesis mediated by transduction for sFlk-1, without delivery of additional morphogens, is sufficient for inducing MSC chondrogenic differentiation. The findings represent a relevant step forward in the field because the method allowed reducing interdonor variability in MSC differentiation efficiency and, importantly, onset of a stable, nonhypertrophic chondrocyte phenotype. : Chondrogenic differentiation of bone marrow-derived mesenchymal stromal/stem cells (MSCs) can be induced by presenting morphogenetic factors or soluble signals but typically suffers from limited efficiency, reproducibility across primary batches, and maintenance of phenotypic stability. Considering the avascular and hypoxic milieu of articular cartilage, we hypothesized that sole inhibition of angiogenesis can provide physiological cues to direct in vivo differentiation of uncommitted MSCs to stable cartilage formation. Human MSCs were retrovirally transduced to express a decoy soluble vascular endothelial growth factor (VEGF) receptor-2 (sFlk1), which efficiently sequesters endogenous VEGF in vivo, seeded on collagen sponges and immediately implanted ectopically in nude mice. Although naïve cells formed vascularized fibrous tissue, sFlk1-MSCs abolished vascular ingrowth into engineered constructs, which efficiently and reproducibly developed into hyaline cartilage. The generated cartilage was phenotypically stable and showed no sign of hypertrophic evolution up to 12 weeks. In vitro analyses indicated that spontaneous chondrogenic differentiation by blockade of angiogenesis was related to the generation of a hypoxic environment, in turn activating the transforming growth factor-β pathway. These findings suggest that VEGF blockade is a robust strategy to enhance cartilage repair by endogenous or grafted mesenchymal progenitors. This article outlines the general paradigm of controlling the fate of implanted stem/progenitor cells by engineering their ability to establish specific microenvironmental conditions rather than directly providing individual morphogenic cues.SIGNIFICANCEChondrogenic differentiation of mesenchymal stromal/stem cells (MSCs) is typically targeted by morphogen delivery, which is often associated with limited efficiency, stability, and robustness. This article proposes a strategy to engineer MSCs with the capacity to establish specific microenvironmental conditions, supporting their own targeted differentiation program. Sole blockade of angiogenesis mediated by transduction for sFlk-1, without delivery of additional morphogens, is sufficient for inducing MSC chondrogenic differentiation. The findings represent a relevant step forward in the field because the method allowed reducing interdonor variability in MSC differentiation efficiency and, importantly, onset of a stable, nonhypertrophic chondrocyte phenotype. This study assessed whether simple inhibition of angiogenesis by vascular endothelial growth factor (VEGF) blockade is sufficient to direct in vivo chondrogenic differentiation of implanted human mesenchymal stromal/stem cells (MSCs). MSCs transduced to express sFlk-1 and directly implanted subcutaneously in nude mice without in vitro preculture spontaneously differentiated into the chondrocytic lineage with a stable phenotype for the observation time-period of 12 weeks. These findings suggest that VEGF blockade is a robust strategy to enhance cartilage repair by endogenous or grafted mesenchymal progenitors. This study assessed whether simple inhibition of angiogenesis by vascular endothelial growth factor (VEGF) blockade is sufficient to direct in vivo chondrogenic differentiation of implanted human mesenchymal stromal/stem cells (MSCs). MSCs transduced to express sFlk‐1 and directly implanted subcutaneously in nude mice without in vitro preculture spontaneously differentiated into the chondrocytic lineage with a stable phenotype for the observation time‐period of 12 weeks. These findings suggest that VEGF blockade is a robust strategy to enhance cartilage repair by endogenous or grafted mesenchymal progenitors. Acknowledgements Chondrogenic differentiation of bone marrow‐derived mesenchymal stromal/stem cells (MSCs) can be induced by presenting morphogenetic factors or soluble signals but typically suffers from limited efficiency, reproducibility across primary batches, and maintenance of phenotypic stability. Considering the avascular and hypoxic milieu of articular cartilage, we hypothesized that sole inhibition of angiogenesis can provide physiological cues to direct in vivo differentiation of uncommitted MSCs to stable cartilage formation. Human MSCs were retrovirally transduced to express a decoy soluble vascular endothelial growth factor (VEGF) receptor‐2 (sFlk1), which efficiently sequesters endogenous VEGF in vivo, seeded on collagen sponges and immediately implanted ectopically in nude mice. Although naïve cells formed vascularized fibrous tissue, sFlk1‐MSCs abolished vascular ingrowth into engineered constructs, which efficiently and reproducibly developed into hyaline cartilage. The generated cartilage was phenotypically stable and showed no sign of hypertrophic evolution up to 12 weeks. In vitro analyses indicated that spontaneous chondrogenic differentiation by blockade of angiogenesis was related to the generation of a hypoxic environment, in turn activating the transforming growth factor‐β pathway. These findings suggest that VEGF blockade is a robust strategy to enhance cartilage repair by endogenous or grafted mesenchymal progenitors. This article outlines the general paradigm of controlling the fate of implanted stem/progenitor cells by engineering their ability to establish specific microenvironmental conditions rather than directly providing individual morphogenic cues. Chondrogenic differentiation of mesenchymal stromal/stem cells (MSCs) is typically targeted by morphogen delivery, which is often associated with limited efficiency, stability, and robustness. This article proposes a strategy to engineer MSCs with the capacity to establish specific microenvironmental conditions, supporting their own targeted differentiation program. Sole blockade of angiogenesis mediated by transduction for sFlk‐1, without delivery of additional morphogens, is sufficient for inducing MSC chondrogenic differentiation. The findings represent a relevant step forward in the field because the method allowed reducing interdonor variability in MSC differentiation efficiency and, importantly, onset of a stable, nonhypertrophic chondrocyte phenotype. : Chondrogenic differentiation of bone marrow-derived mesenchymal stromal/stem cells (MSCs) can be induced by presenting morphogenetic factors or soluble signals but typically suffers from limited efficiency, reproducibility across primary batches, and maintenance of phenotypic stability. Considering the avascular and hypoxic milieu of articular cartilage, we hypothesized that sole inhibition of angiogenesis can provide physiological cues to direct in vivo differentiation of uncommitted MSCs to stable cartilage formation. Human MSCs were retrovirally transduced to express a decoy soluble vascular endothelial growth factor (VEGF) receptor-2 (sFlk1), which efficiently sequesters endogenous VEGF in vivo, seeded on collagen sponges and immediately implanted ectopically in nude mice. Although naïve cells formed vascularized fibrous tissue, sFlk1-MSCs abolished vascular ingrowth into engineered constructs, which efficiently and reproducibly developed into hyaline cartilage. The generated cartilage was phenotypically stable and showed no sign of hypertrophic evolution up to 12 weeks. In vitro analyses indicated that spontaneous chondrogenic differentiation by blockade of angiogenesis was related to the generation of a hypoxic environment, in turn activating the transforming growth factor-β pathway. These findings suggest that VEGF blockade is a robust strategy to enhance cartilage repair by endogenous or grafted mesenchymal progenitors. This article outlines the general paradigm of controlling the fate of implanted stem/progenitor cells by engineering their ability to establish specific microenvironmental conditions rather than directly providing individual morphogenic cues. Chondrogenic differentiation of mesenchymal stromal/stem cells (MSCs) is typically targeted by morphogen delivery, which is often associated with limited efficiency, stability, and robustness. This article proposes a strategy to engineer MSCs with the capacity to establish specific microenvironmental conditions, supporting their own targeted differentiation program. Sole blockade of angiogenesis mediated by transduction for sFlk-1, without delivery of additional morphogens, is sufficient for inducing MSC chondrogenic differentiation. The findings represent a relevant step forward in the field because the method allowed reducing interdonor variability in MSC differentiation efficiency and, importantly, onset of a stable, nonhypertrophic chondrocyte phenotype. |
Author | Schaeren, Stefan Gueven, Sinan Tsaryk, Roman Medeiros da Cunha, Carolina M. Marsano, Anna Banfi, Andrea Stuedle, Chiara Barbero, Andrea Centola, Matteo Helmrich, Uta Martin, Ivan Ghanaati, Shahram Kirkpatrick, James C. Barbeck, Mike |
Author_xml | – sequence: 1 givenname: Anna surname: Marsano fullname: Marsano, Anna – sequence: 2 givenname: Carolina M. surname: Medeiros da Cunha fullname: Medeiros da Cunha, Carolina M. – sequence: 3 givenname: Shahram surname: Ghanaati fullname: Ghanaati, Shahram – sequence: 4 givenname: Sinan surname: Gueven fullname: Gueven, Sinan – sequence: 5 givenname: Matteo surname: Centola fullname: Centola, Matteo – sequence: 6 givenname: Roman surname: Tsaryk fullname: Tsaryk, Roman – sequence: 7 givenname: Mike surname: Barbeck fullname: Barbeck, Mike – sequence: 8 givenname: Chiara surname: Stuedle fullname: Stuedle, Chiara – sequence: 9 givenname: Andrea surname: Barbero fullname: Barbero, Andrea – sequence: 10 givenname: Uta surname: Helmrich fullname: Helmrich, Uta – sequence: 11 givenname: Stefan surname: Schaeren fullname: Schaeren, Stefan – sequence: 12 givenname: James C. surname: Kirkpatrick fullname: Kirkpatrick, James C. – sequence: 13 givenname: Andrea surname: Banfi fullname: Banfi, Andrea email: ivan.martin@usb.ch – sequence: 14 givenname: Ivan surname: Martin fullname: Martin, Ivan email: Andrea.Banfi@usb.ch |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27460852$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkUFvFCEYholpY2vt1aMh8eJltsAMzExMTNqxrU3aaLK1V0KB2aEysMLMNnvzJ-hf9JfIdNuNepELEJ7v5Xu_9wXYcd5pAF5hNKM1Y0dRDv2MIEwzlBP8DOwTTMuM0QrtbM-s2AOHMd6htFjNaoKegz1SFgxVlOyDn_Old4Nw2o8RXjh4Y1YeNp13KviFdjqaCH0LT9LH8EqE4O9_ff_xQQez0gpe6aid7Na9sPDzA28GH2CjrY3wdg1PrJdfjVvAGxHlaEWAp075odPWpIrzJDZ08EzIqWhuFk7YBL8Eu62wUR8-7gfgy9npdfMxu_x0ftEcX2ayKBHKJEZ1GkIpEEYlq1WFJaUkmW41qluFFW0VUaguKoKkqGXy2-aypaoVSjIs8gPwfqO7HG97raR2QxCWL4PpRVhzLwz_-8WZji_8ilNc1awoksDbR4Hgv406Drw3USbvm2lyXBFWkqLAZULf_IPe-TEkv5ETktRYlRckUbMNJYOPMeh22wxGfAqcT4HzKXA-BZ4KXv9pYYs_xZuAdxvg3li9_o8cnzfXeboxiknqGeW_AbcKvjU |
CitedBy_id | crossref_primary_10_1177_03635465211005102 crossref_primary_10_1002_mrd_23683 crossref_primary_10_1126_scitranslmed_aav7756 crossref_primary_10_3390_bioengineering8040046 crossref_primary_10_1016_j_bioactmat_2017_06_001 crossref_primary_10_1155_2020_8837654 crossref_primary_10_3390_biomimetics6020040 crossref_primary_10_1016_j_gendis_2020_10_006 crossref_primary_10_1073_pnas_1720658115 crossref_primary_10_1080_15476278_2021_1991199 crossref_primary_10_1002_jbmr_3599 crossref_primary_10_1080_15548627_2021_1872227 crossref_primary_10_3390_ijms242316783 crossref_primary_10_1016_j_bone_2020_115686 crossref_primary_10_1016_j_ijbiomac_2022_09_065 crossref_primary_10_3389_fcell_2021_703038 crossref_primary_10_1007_s12015_021_10162_6 crossref_primary_10_1016_j_matdes_2022_110981 crossref_primary_10_1016_j_mtbio_2019_100009 crossref_primary_10_1002_adhm_202202550 crossref_primary_10_3390_cells11244034 crossref_primary_10_1080_09537104_2020_1775188 crossref_primary_10_1016_j_jot_2017_03_005 crossref_primary_10_1096_fj_202302391RR crossref_primary_10_1002_jor_23670 crossref_primary_10_1007_s10439_019_02272_7 crossref_primary_10_1002_advs_202100351 crossref_primary_10_1038_s41526_017_0032_x crossref_primary_10_1089_ten_tea_2018_0211 crossref_primary_10_1007_s00018_021_04105_0 crossref_primary_10_1002_sctm_19_0319 crossref_primary_10_1016_j_yexcr_2020_112436 crossref_primary_10_1016_j_biotechadv_2018_07_004 crossref_primary_10_3390_ijms18112478 crossref_primary_10_3389_fbioe_2017_00032 |
Cites_doi | 10.1111/j.1749-6632.2000.tb06320.x 10.1172/JCI37630 10.1159/000046610 10.1089/107632703762687573 10.1016/B978-0-12-391498-9.00005-X 10.1126/science.1168755 10.1002/jcp.22605 10.1073/pnas.0503544102 10.1242/jcs.113.1.59 10.1073/pnas.1000302107 10.1359/jbmr.080103 10.1172/JCI117156 10.1002/art.24153 10.1186/s13287-015-0075-4 10.1006/bbrc.1996.1355 10.1002/jcp.20238 10.1242/jcs.062901 10.1089/ten.tec.2011.0413 10.1016/j.injury.2008.01.038 10.1002/stem.291 10.1158/1541-7786.315.2.6 10.1016/j.biomaterials.2012.08.045 10.1016/S0014-4827(03)00138-1 10.1016/j.joca.2007.09.003 10.5966/sctm.2013-0079 10.1002/jcp.21446 10.1038/nrrheum.2010.196 10.1089/ten.2005.11.1421 10.1002/term.1661 10.1016/0304-4165(86)90306-5 10.1002/dvdy.1212 10.1006/excr.1997.3858 10.1002/art.10950 10.1016/j.bone.2005.04.040 10.1016/j.cell.2014.12.002 10.1080/14653240802398845 10.1002/art.24443 10.1016/j.joca.2013.07.017 10.1016/j.aanat.2014.11.003 10.1038/9467 10.1073/pnas.0803194105 10.1073/pnas.1410977111 10.1002/1529-0131(200107)44:7<1608::AID-ART284>3.0.CO;2-T 10.1089/ten.tea.2012.0455 10.1006/mvre.2002.2434 10.1172/JCI200419383 10.1126/science.1181928 10.1016/j.bbrc.2005.07.145 10.1038/mt.2008.5 10.1016/j.biomaterials.2011.07.041 10.1016/j.matbio.2004.06.003 |
ContentType | Journal Article |
Copyright | 2016 AlphaMed Press AlphaMed Press. 2016. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. AlphaMed Press 2016 |
Copyright_xml | – notice: 2016 AlphaMed Press – notice: AlphaMed Press. – notice: 2016. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: AlphaMed Press 2016 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7X7 7XB 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M7P PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.5966/sctm.2015-0321 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) ProQuest - Health & Medical Complete保健、医学与药学数据库 ProQuest Central (purchase pre-March 2016) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection AUTh Library subscriptions: ProQuest Central ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection (Proquest) (PQ_SDU_P3) ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) Biological Science Database Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic Publicly Available Content Database MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
DocumentTitleAlternate | Spontaneous Chondrogenesis by VEGF Blockade |
EISSN | 2157-6580 |
EndPage | 1738 |
ExternalDocumentID | 10_5966_sctm_2015_0321 27460852 SCT320165121730 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | 0R~ 1OC 24P 53G 5RE 7X7 8FE 8FH 8FI 8FJ AAHHS AAKDD AAPXW AAVAP ABPTD ABUWG ABXVV ACCFJ ACXQS ADBBV ADKYN ADZMN AEEZP AENEX AEQDE AFKRA AIWBW AJAOE AJBDE ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AOIJS AVUZU BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI CCPQU DIK EBD EBS EJD EMOBN FYUFA GROUPED_DOAJ H13 HCIFZ HMCUK HYE HZ~ LK8 M7P O9- OK1 OVD PIMPY PQQKQ PROAC RHI ROX RPM SV3 TOX UKHRP WIN CGR CUY CVF ECM EIF J6A NPM OJZSN AAYXX CITATION 3V. 7XB 8FK AZQEC DWQXO GNUQQ K9. PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c4700-c1095967a010769d81c552215fe09fd1d5fd2d094820ca9c608f3cf5dfadc61a3 |
IEDL.DBID | RPM |
ISSN | 2157-6564 |
IngestDate | Tue Sep 17 21:21:10 EDT 2024 Tue Aug 27 04:38:08 EDT 2024 Fri Sep 13 08:17:11 EDT 2024 Fri Aug 23 00:26:42 EDT 2024 Fri May 24 00:06:05 EDT 2024 Sat Aug 24 01:01:30 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | Hypoxia Chondrogenesis Mesenchymal stromal/stem cells Vascular endothelial growth factor blockade |
Language | English |
License | AlphaMed Press. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4700-c1095967a010769d81c552215fe09fd1d5fd2d094820ca9c608f3cf5dfadc61a3 |
Notes | Contributed equally. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.proquest.com/docview/2289668342/abstract/?pq-origsite=%requestingapplication% |
PMID | 27460852 |
PQID | 2289668342 |
PQPubID | 4370291 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5189644 proquest_miscellaneous_1826724417 proquest_journals_2289668342 crossref_primary_10_5966_sctm_2015_0321 pubmed_primary_27460852 wiley_primary_10_5966_sctm_2015_0321_SCT320165121730 |
PublicationCentury | 2000 |
PublicationDate | December 2016 |
PublicationDateYYYYMMDD | 2016-12-01 |
PublicationDate_xml | – month: 12 year: 2016 text: December 2016 |
PublicationDecade | 2010 |
PublicationPlace | Durham, NC, USA |
PublicationPlace_xml | – name: Durham, NC, USA – name: United States – name: Oxford |
PublicationTitle | Stem cells translational medicine |
PublicationTitleAlternate | Stem Cells Transl Med |
PublicationYear | 2016 |
Publisher | AlphaMed Press Oxford University Press |
Publisher_xml | – name: AlphaMed Press – name: Oxford University Press |
References | 2001; 222 2010; 107 2013; 21 2005; 335 2004; 23 2008; 39 2008; 105 2012; 18 1998; 238 2004; 2 2001; 44 2009; 119 2001; 106 1996; 226 2013; 19 2014; 3 2010; 28 2005; 102 2003; 9 2008; 23 2003; 48 1980 2005; 37 2003; 287 2009; 323 2015; 160 2015; 6 2000; 113 2010; 327 2009; 60 2008; 16 2010; 123 2011; 32 2008; 10 2015; 9 2014; 111 1999; 5 2012; 33 2011; 7 2000; 902 2011; 226 2014; 108 1986; 883 2004; 113 2002; 64 2005; 203 2015; 198 2008; 216 2016 1994; 93 2005; 11 18366089 - J Cell Physiol. 2008 Sep;216(3):708-15 26990890 - Anat Histol Embryol. 2017 Feb;46(1):43-50 22070632 - Tissue Eng Part C Methods. 2012 Apr;18(4):283-92 12625958 - Tissue Eng. 2003 Feb;9(1):95-103 24512714 - Curr Top Dev Biol. 2014;108:319-38 25621374 - Ann Anat. 2015 Mar;198:1-10 20110505 - Science. 2010 Jan 29;327(5965):580-3 16259597 - Tissue Eng. 2005 Sep-Oct;11(9-10):1421-8 14722611 - J Clin Invest. 2004 Jan;113(2):188-99 19404941 - Arthritis Rheum. 2009 May;60(5):1390-405 11465712 - Arthritis Rheum. 2001 Jul;44(7):1608-19 15464359 - Matrix Biol. 2004 Aug;23(5):267-76 25594184 - Cell. 2015 Jan 15;160(1-2):285-98 20501701 - J Cell Sci. 2010 Jun 15;123(Pt 12):2068-76 23611597 - Tissue Eng Part A. 2013 Sep;19(17-18):1960-71 23225781 - J Tissue Eng Regen Med. 2015 Dec;9(12 ):1394-403 24436440 - Stem Cells Transl Med. 2014 Feb;3(2):241-54 18632559 - Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10185-90 10371499 - Nat Med. 1999 Jun;5(6):623-8 12799186 - Exp Cell Res. 2003 Jul 1;287(1):98-105 21792913 - J Cell Physiol. 2011 Oct;226(10):2562-70 18985474 - Cytotherapy. 2008;10(7):676-85 10591625 - J Cell Sci. 2000 Jan;113 ( Pt 1):59-69 18334985 - Mol Ther. 2008 Apr;16(4):718-25 11815711 - Acta Haematol. 2001;106(4):148-56 19116905 - Arthritis Rheum. 2009 Jan;60(1):155-65 18433297 - J Bone Miner Res. 2008 May;23(5):596-609 16023419 - Bone. 2005 Sep;37(3):313-22 12746904 - Arthritis Rheum. 2003 May;48(5):1315-25 11747085 - Dev Dyn. 2001 Nov;222(3):522-33 19307726 - J Clin Invest. 2009 Apr;119(4):964-75 8806634 - Biochem Biophys Res Commun. 1996 Sep 13;226(2):324-8 22999467 - Biomaterials. 2012 Dec;33(35):8967-74 21119608 - Nat Rev Rheumatol. 2011 Jan;7(1):33-42 12453433 - Microvasc Res. 2002 Nov;64(3):384-97 9457080 - Exp Cell Res. 1998 Jan 10;238(1):265-72 17945514 - Osteoarthritis Cartilage. 2008 Mar;16(3):279-86 16172397 - Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):14016-21 15235107 - Mol Cancer Res. 2004 Jun;2(6):315-26 18313473 - Injury. 2008 Apr;39 Suppl 1:S58-65 25205812 - Proc Natl Acad Sci U S A. 2014 Sep 23;111(38):13954-9 20406908 - Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7251-6 20039367 - Stem Cells. 2010 Mar 31;28(3):611-9 23933379 - Osteoarthritis Cartilage. 2013 Nov;21(11):1627-37 25900045 - Stem Cell Res Ther. 2015 Apr 23;6:84 21821280 - Biomaterials. 2011 Nov;32(32):8150-60 7512992 - J Clin Invest. 1994 Apr;93(4):1722-32 16105658 - Biochem Biophys Res Commun. 2005 Sep 30;335(3):793-8 15521064 - J Cell Physiol. 2005 May;203(2):398-409 7418319 - Clin Orthop Relat Res. 1980 Sep;(151):294-307 19229034 - Science. 2009 Feb 20;323(5917):1050-3 10865845 - Ann N Y Acad Sci. 2000 May;902:249-62; discussion 262-4 3091074 - Biochim Biophys Acta. 1986 Sep 4;883(2):173-7 Chan (2021122705121417400_R10) 2015; 160 Murata (2021122705121417400_R11) 2008; 16 Kapoor (2021122705121417400_R46) 2011; 7 Ashton (2021122705121417400_R5) 1980 Boyette (2021122705121417400_R37) 2014; 3 Jacobsen (2021122705121417400_R9) 2008; 23 Kaigler (2021122705121417400_R35) 2003; 9 Leijten (2021122705121417400_R40) 2014; 111 Kendall (2021122705121417400_R12) 1996; 226 Pufe (2021122705121417400_R34) 2004; 23 Maes (2021122705121417400_R36) 2004; 113 Dell’Accio (2021122705121417400_R50) 2001; 44 Ghanaati (2021122705121417400_R30) 2011; 32 Pelttari (2021122705121417400_R2) 2008; 39 Carmeliet (2021122705121417400_R7) 2000; 902 Ousema (2021122705121417400_R47) 2012; 33 Yin (2021122705121417400_R33) 2001; 222 Sabatino (2021122705121417400_R16) 2015; 9 Hollander (2021122705121417400_R26) 1994; 93 Bénazet (2021122705121417400_R32) 2009; 323 Centola (2021122705121417400_R28) 2013; 19 Schneevoigt (2021122705121417400_R31) 2016 Boilard (2021122705121417400_R45) 2010; 327 Scotti (2021122705121417400_R3) 2010; 107 Ebos (2021122705121417400_R13) 2004; 2 Niida (2021122705121417400_R49) 2005; 102 Zhu (2021122705121417400_R44) 2013; 21 Horn (2021122705121417400_R18) 2008; 10 Zychlinski (2021122705121417400_R52) 2008; 16 Johnstone (2021122705121417400_R1) 1998; 238 Gerber (2021122705121417400_R8) 1999; 5 Montini (2021122705121417400_R51) 2009; 119 Barbero (2021122705121417400_R24) 2003; 48 Kuhnert (2021122705121417400_R21) 2008; 105 Pattappa (2021122705121417400_R38) 2011; 226 Ferrara (2021122705121417400_R6) 2001; 106 Helmrich (2021122705121417400_R23) 2012; 18 Kanichai (2021122705121417400_R17) 2008; 216 Kubo (2021122705121417400_R15) 2009; 60 Carlevaro (2021122705121417400_R4) 2000; 113 Bianchi (2021122705121417400_R19) 2003; 287 Aldridge (2021122705121417400_R48) 2005; 335 Unger (2021122705121417400_R29) 2002; 64 Matsumoto (2021122705121417400_R14) 2009; 60 Farndale (2021122705121417400_R27) 1986; 883 Misteli (2021122705121417400_R22) 2010; 28 Moretti (2021122705121417400_R25) 2005; 11 Tonnarelli (2021122705121417400_R53) 2014; 108 Das (2021122705121417400_R42) 2015; 198 Karamboulas (2021122705121417400_R43) 2010; 123 Robins (2021122705121417400_R41) 2005; 37 Solchaga (2021122705121417400_R20) 2005; 203 Bornes (2021122705121417400_R39) 2015; 6 |
References_xml | – volume: 60 start-page: 1390 year: 2009 end-page: 1405 article-title: Cartilage repair in a rat model of osteoarthritis through intraarticular transplantation of muscle-derived stem cells expressing bone morphogenetic protein 4 and soluble Flt-1 publication-title: Arthritis Rheum – volume: 23 start-page: 267 year: 2004 end-page: 276 article-title: Endostatin/collagen XVIII--an inhibitor of angiogenesis--is expressed in cartilage and fibrocartilage publication-title: Matrix Biol – volume: 238 start-page: 265 year: 1998 end-page: 272 article-title: In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells publication-title: Exp Cell Res – volume: 11 start-page: 1421 year: 2005 end-page: 1428 article-title: Effects of in vitro preculture on in vivo development of human engineered cartilage in an ectopic model publication-title: Tissue Eng – volume: 226 start-page: 2562 year: 2011 end-page: 2570 article-title: The metabolism of human mesenchymal stem cells during proliferation and differentiation publication-title: J Cell Physiol – volume: 113 start-page: 188 year: 2004 end-page: 199 article-title: Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival publication-title: J Clin Invest – volume: 105 start-page: 10185 year: 2008 end-page: 10190 article-title: Soluble receptor-mediated selective inhibition of VEGFR and PDGFRbeta signaling during physiologic and tumor angiogenesis publication-title: Proc Natl Acad Sci USA – volume: 323 start-page: 1050 year: 2009 end-page: 1053 article-title: A self-regulatory system of interlinked signaling feedback loops controls mouse limb patterning publication-title: Science – volume: 3 start-page: 241 year: 2014 end-page: 254 article-title: Human bone marrow-derived mesenchymal stem cells display enhanced clonogenicity but impaired differentiation with hypoxic preconditioning publication-title: Stem Cells Translational Medicine – volume: 19 start-page: 1960 year: 2013 end-page: 1971 article-title: Scaffold-based delivery of a clinically relevant anti-angiogenic drug promotes the formation of in vivo stable cartilage publication-title: Tissue Eng Part A – start-page: 294 issue: 151 year: 1980 end-page: 307 article-title: Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo publication-title: Clin Orthop Relat Res – volume: 123 start-page: 2068 year: 2010 end-page: 2076 article-title: Regulation of BMP-dependent chondrogenesis in early limb mesenchyme by TGFbeta signals publication-title: J Cell Sci – volume: 5 start-page: 623 year: 1999 end-page: 628 article-title: VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation publication-title: Nat Med – volume: 2 start-page: 315 year: 2004 end-page: 326 article-title: A naturally occurring soluble form of vascular endothelial growth factor receptor 2 detected in mouse and human plasma publication-title: Mol Cancer Res – volume: 9 start-page: 1394 year: 2015 end-page: 1403 article-title: Cartilage graft engineering by co-culturing primary human articular chondrocytes with human bone marrow stromal cells publication-title: J Tissue Eng Regen Med – volume: 37 start-page: 313 year: 2005 end-page: 322 article-title: Hypoxia induces chondrocyte-specific gene expression in mesenchymal cells in association with transcriptional activation of Sox9 publication-title: Bone – volume: 21 start-page: 1627 year: 2013 end-page: 1637 article-title: Basic science and clinical application of platelet-rich plasma for cartilage defects and osteoarthritis: a review publication-title: Osteoarthritis Cartilage – volume: 102 start-page: 14016 year: 2005 end-page: 14021 article-title: VEGF receptor 1 signaling is essential for osteoclast development and bone marrow formation in colony-stimulating factor 1-deficient mice publication-title: Proc Natl Acad Sci USA – volume: 7 start-page: 33 year: 2011 end-page: 42 article-title: Role of proinflammatory cytokines in the pathophysiology of osteoarthritis publication-title: Nat Rev Rheumatol – volume: 287 start-page: 98 year: 2003 end-page: 105 article-title: Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2 publication-title: Exp Cell Res – volume: 160 start-page: 285 year: 2015 end-page: 298 article-title: Identification and specification of the mouse skeletal stem cell publication-title: Cell – volume: 883 start-page: 173 year: 1986 end-page: 177 article-title: Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue publication-title: Biochim Biophys Acta – volume: 6 start-page: 84 year: 2015 article-title: Hypoxic culture of bone marrow-derived mesenchymal stromal stem cells differentially enhances in vitro chondrogenesis within cell-seeded collagen and hyaluronic acid porous scaffolds publication-title: Stem Cell Res Ther – volume: 327 start-page: 580 year: 2010 end-page: 583 article-title: Platelets amplify inflammation in arthritis via collagen-dependent microparticle production publication-title: Science – volume: 113 start-page: 59 year: 2000 end-page: 69 article-title: Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: Auto-paracrine role during endochondral bone formation publication-title: J Cell Sci – volume: 48 start-page: 1315 year: 2003 end-page: 1325 article-title: Plasticity of clonal populations of dedifferentiated adult human articular chondrocytes publication-title: Arthritis Rheum – volume: 39 start-page: S58 year: 2008 end-page: S65 article-title: The use of mesenchymal stem cells for chondrogenesis publication-title: Injury – volume: 93 start-page: 1722 year: 1994 end-page: 1732 article-title: Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay publication-title: J Clin Invest – volume: 216 start-page: 708 year: 2008 end-page: 715 article-title: Hypoxia promotes chondrogenesis in rat mesenchymal stem cells: A role for AKT and hypoxia-inducible factor (HIF)-1α publication-title: J Cell Physiol – volume: 23 start-page: 596 year: 2008 end-page: 609 article-title: Bone formation during distraction osteogenesis is dependent on both VEGFR1 and VEGFR2 signaling publication-title: J Bone Miner Res – volume: 9 start-page: 95 year: 2003 end-page: 103 article-title: Role of vascular endothelial growth factor in bone marrow stromal cell modulation of endothelial cells publication-title: Tissue Eng – volume: 33 start-page: 8967 year: 2012 end-page: 8974 article-title: The inhibition by interleukin 1 of MSC chondrogenesis and the development of biomechanical properties in biomimetic 3D woven PCL scaffolds publication-title: Biomaterials – volume: 16 start-page: 279 year: 2008 end-page: 286 article-title: The potential role of vascular endothelial growth factor (VEGF) in cartilage: How the angiogenic factor could be involved in the pathogenesis of osteoarthritis? publication-title: Osteoarthritis Cartilage – volume: 108 start-page: 319 year: 2014 end-page: 338 article-title: Re-engineering development to instruct tissue regeneration publication-title: Curr Top Dev Biol – volume: 106 start-page: 148 year: 2001 end-page: 156 article-title: The role of vascular endothelial growth factor in angiogenesis publication-title: Acta Haematol – volume: 226 start-page: 324 year: 1996 end-page: 328 article-title: Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR publication-title: Biochem Biophys Res Commun – volume: 44 start-page: 1608 year: 2001 end-page: 1619 article-title: Molecular markers predictive of the capacity of expanded human articular chondrocytes to form stable cartilage in vivo publication-title: Arthritis Rheum – volume: 119 start-page: 964 year: 2009 end-page: 975 article-title: The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy publication-title: J Clin Invest – volume: 222 start-page: 522 year: 2001 end-page: 533 article-title: Vascular regression is required for mesenchymal condensation and chondrogenesis in the developing limb publication-title: Dev Dyn – volume: 203 start-page: 398 year: 2005 end-page: 409 article-title: FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells publication-title: J Cell Physiol – volume: 60 start-page: 155 year: 2009 end-page: 165 article-title: Blocking vascular endothelial growth factor with soluble Flt-1 improves the chondrogenic potential of mouse skeletal muscle-derived stem cells publication-title: Arthritis Rheum – volume: 16 start-page: 718 year: 2008 end-page: 725 article-title: Physiological promoters reduce the genotoxic risk of integrating gene vectors publication-title: Mol Ther – volume: 902 start-page: 249 year: 2000 end-page: 262; discussion 262–264 article-title: Molecular basis of angiogenesis. Role of VEGF and VE-cadherin publication-title: Ann N Y Acad Sci – volume: 32 start-page: 8150 year: 2011 end-page: 8160 article-title: Scaffold vascularization in vivo driven by primary human osteoblasts in concert with host inflammatory cells publication-title: Biomaterials – volume: 18 start-page: 283 year: 2012 end-page: 292 article-title: Generation of human adult mesenchymal stromal/stem cells expressing defined xenogenic vascular endothelial growth factor levels by optimized transduction and flow cytometry purification publication-title: Tissue Eng Part C Methods – year: 2016 article-title: In vitro expression of the extracellular matrix components aggrecan, collagen types I and II by articular cartilage-derived chondrocytes publication-title: Anat Histol Embryol – volume: 107 start-page: 7251 year: 2010 end-page: 7256 article-title: Recapitulation of endochondral bone formation using human adult mesenchymal stem cells as a paradigm for developmental engineering publication-title: Proc Natl Acad Sci USA – volume: 28 start-page: 611 year: 2010 end-page: 619 article-title: High-throughput flow cytometry purification of transduced progenitors expressing defined levels of vascular endothelial growth factor induces controlled angiogenesis in vivo publication-title: Stem Cells – volume: 64 start-page: 384 year: 2002 end-page: 397 article-title: In vitro expression of the endothelial phenotype: Comparative study of primary isolated cells and cell lines, including the novel cell line HPMEC-ST1.6R publication-title: Microvasc Res – volume: 10 start-page: 676 year: 2008 end-page: 685 article-title: Isolation of human mesenchymal stromal cells is more efficient by red blood cell lysis publication-title: Cytotherapy – volume: 198 start-page: 1 year: 2015 end-page: 10 article-title: TGF-β2 is involved in the preservation of the chondrocyte phenotype under hypoxic conditions publication-title: Ann Anat – volume: 335 start-page: 793 year: 2005 end-page: 798 article-title: Vascular endothelial growth factor receptors in osteoclast differentiation and function publication-title: Biochem Biophys Res Commun – volume: 111 start-page: 13954 year: 2014 end-page: 13959 article-title: Metabolic programming of mesenchymal stromal cells by oxygen tension directs chondrogenic cell fate publication-title: Proc Natl Acad Sci USA – volume: 902 start-page: 249 year: 2000 ident: 2021122705121417400_R7 article-title: Molecular basis of angiogenesis. Role of VEGF and VE-cadherin publication-title: Ann N Y Acad Sci doi: 10.1111/j.1749-6632.2000.tb06320.x contributor: fullname: Carmeliet – volume: 119 start-page: 964 year: 2009 ident: 2021122705121417400_R51 article-title: The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy publication-title: J Clin Invest doi: 10.1172/JCI37630 contributor: fullname: Montini – volume: 106 start-page: 148 year: 2001 ident: 2021122705121417400_R6 article-title: The role of vascular endothelial growth factor in angiogenesis publication-title: Acta Haematol doi: 10.1159/000046610 contributor: fullname: Ferrara – volume: 9 start-page: 95 year: 2003 ident: 2021122705121417400_R35 article-title: Role of vascular endothelial growth factor in bone marrow stromal cell modulation of endothelial cells publication-title: Tissue Eng doi: 10.1089/107632703762687573 contributor: fullname: Kaigler – volume: 108 start-page: 319 year: 2014 ident: 2021122705121417400_R53 article-title: Re-engineering development to instruct tissue regeneration publication-title: Curr Top Dev Biol doi: 10.1016/B978-0-12-391498-9.00005-X contributor: fullname: Tonnarelli – volume: 323 start-page: 1050 year: 2009 ident: 2021122705121417400_R32 article-title: A self-regulatory system of interlinked signaling feedback loops controls mouse limb patterning publication-title: Science doi: 10.1126/science.1168755 contributor: fullname: Bénazet – volume: 226 start-page: 2562 year: 2011 ident: 2021122705121417400_R38 article-title: The metabolism of human mesenchymal stem cells during proliferation and differentiation publication-title: J Cell Physiol doi: 10.1002/jcp.22605 contributor: fullname: Pattappa – volume: 102 start-page: 14016 year: 2005 ident: 2021122705121417400_R49 article-title: VEGF receptor 1 signaling is essential for osteoclast development and bone marrow formation in colony-stimulating factor 1-deficient mice publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0503544102 contributor: fullname: Niida – volume: 113 start-page: 59 year: 2000 ident: 2021122705121417400_R4 article-title: Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: Auto-paracrine role during endochondral bone formation publication-title: J Cell Sci doi: 10.1242/jcs.113.1.59 contributor: fullname: Carlevaro – volume: 107 start-page: 7251 year: 2010 ident: 2021122705121417400_R3 article-title: Recapitulation of endochondral bone formation using human adult mesenchymal stem cells as a paradigm for developmental engineering publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1000302107 contributor: fullname: Scotti – volume: 23 start-page: 596 year: 2008 ident: 2021122705121417400_R9 article-title: Bone formation during distraction osteogenesis is dependent on both VEGFR1 and VEGFR2 signaling publication-title: J Bone Miner Res doi: 10.1359/jbmr.080103 contributor: fullname: Jacobsen – volume: 93 start-page: 1722 year: 1994 ident: 2021122705121417400_R26 article-title: Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay publication-title: J Clin Invest doi: 10.1172/JCI117156 contributor: fullname: Hollander – volume: 60 start-page: 155 year: 2009 ident: 2021122705121417400_R15 article-title: Blocking vascular endothelial growth factor with soluble Flt-1 improves the chondrogenic potential of mouse skeletal muscle-derived stem cells publication-title: Arthritis Rheum doi: 10.1002/art.24153 contributor: fullname: Kubo – volume: 6 start-page: 84 year: 2015 ident: 2021122705121417400_R39 article-title: Hypoxic culture of bone marrow-derived mesenchymal stromal stem cells differentially enhances in vitro chondrogenesis within cell-seeded collagen and hyaluronic acid porous scaffolds publication-title: Stem Cell Res Ther doi: 10.1186/s13287-015-0075-4 contributor: fullname: Bornes – volume: 226 start-page: 324 year: 1996 ident: 2021122705121417400_R12 article-title: Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR publication-title: Biochem Biophys Res Commun doi: 10.1006/bbrc.1996.1355 contributor: fullname: Kendall – volume: 203 start-page: 398 year: 2005 ident: 2021122705121417400_R20 article-title: FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells publication-title: J Cell Physiol doi: 10.1002/jcp.20238 contributor: fullname: Solchaga – volume: 123 start-page: 2068 year: 2010 ident: 2021122705121417400_R43 article-title: Regulation of BMP-dependent chondrogenesis in early limb mesenchyme by TGFbeta signals publication-title: J Cell Sci doi: 10.1242/jcs.062901 contributor: fullname: Karamboulas – volume: 18 start-page: 283 year: 2012 ident: 2021122705121417400_R23 article-title: Generation of human adult mesenchymal stromal/stem cells expressing defined xenogenic vascular endothelial growth factor levels by optimized transduction and flow cytometry purification publication-title: Tissue Eng Part C Methods doi: 10.1089/ten.tec.2011.0413 contributor: fullname: Helmrich – volume: 39 start-page: S58 year: 2008 ident: 2021122705121417400_R2 article-title: The use of mesenchymal stem cells for chondrogenesis publication-title: Injury doi: 10.1016/j.injury.2008.01.038 contributor: fullname: Pelttari – volume: 28 start-page: 611 year: 2010 ident: 2021122705121417400_R22 article-title: High-throughput flow cytometry purification of transduced progenitors expressing defined levels of vascular endothelial growth factor induces controlled angiogenesis in vivo publication-title: Stem Cells doi: 10.1002/stem.291 contributor: fullname: Misteli – volume: 2 start-page: 315 year: 2004 ident: 2021122705121417400_R13 article-title: A naturally occurring soluble form of vascular endothelial growth factor receptor 2 detected in mouse and human plasma publication-title: Mol Cancer Res doi: 10.1158/1541-7786.315.2.6 contributor: fullname: Ebos – volume: 33 start-page: 8967 year: 2012 ident: 2021122705121417400_R47 article-title: The inhibition by interleukin 1 of MSC chondrogenesis and the development of biomechanical properties in biomimetic 3D woven PCL scaffolds publication-title: Biomaterials doi: 10.1016/j.biomaterials.2012.08.045 contributor: fullname: Ousema – volume: 287 start-page: 98 year: 2003 ident: 2021122705121417400_R19 article-title: Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2 publication-title: Exp Cell Res doi: 10.1016/S0014-4827(03)00138-1 contributor: fullname: Bianchi – volume: 16 start-page: 279 year: 2008 ident: 2021122705121417400_R11 article-title: The potential role of vascular endothelial growth factor (VEGF) in cartilage: How the angiogenic factor could be involved in the pathogenesis of osteoarthritis? publication-title: Osteoarthritis Cartilage doi: 10.1016/j.joca.2007.09.003 contributor: fullname: Murata – volume: 3 start-page: 241 year: 2014 ident: 2021122705121417400_R37 article-title: Human bone marrow-derived mesenchymal stem cells display enhanced clonogenicity but impaired differentiation with hypoxic preconditioning publication-title: Stem Cells Translational Medicine doi: 10.5966/sctm.2013-0079 contributor: fullname: Boyette – volume: 216 start-page: 708 year: 2008 ident: 2021122705121417400_R17 article-title: Hypoxia promotes chondrogenesis in rat mesenchymal stem cells: A role for AKT and hypoxia-inducible factor (HIF)-1α publication-title: J Cell Physiol doi: 10.1002/jcp.21446 contributor: fullname: Kanichai – volume: 7 start-page: 33 year: 2011 ident: 2021122705121417400_R46 article-title: Role of proinflammatory cytokines in the pathophysiology of osteoarthritis publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2010.196 contributor: fullname: Kapoor – year: 2016 ident: 2021122705121417400_R31 article-title: In vitro expression of the extracellular matrix components aggrecan, collagen types I and II by articular cartilage-derived chondrocytes publication-title: Anat Histol Embryol contributor: fullname: Schneevoigt – volume: 11 start-page: 1421 year: 2005 ident: 2021122705121417400_R25 article-title: Effects of in vitro preculture on in vivo development of human engineered cartilage in an ectopic model publication-title: Tissue Eng doi: 10.1089/ten.2005.11.1421 contributor: fullname: Moretti – volume: 9 start-page: 1394 year: 2015 ident: 2021122705121417400_R16 article-title: Cartilage graft engineering by co-culturing primary human articular chondrocytes with human bone marrow stromal cells publication-title: J Tissue Eng Regen Med doi: 10.1002/term.1661 contributor: fullname: Sabatino – volume: 883 start-page: 173 year: 1986 ident: 2021122705121417400_R27 article-title: Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue publication-title: Biochim Biophys Acta doi: 10.1016/0304-4165(86)90306-5 contributor: fullname: Farndale – volume: 222 start-page: 522 year: 2001 ident: 2021122705121417400_R33 article-title: Vascular regression is required for mesenchymal condensation and chondrogenesis in the developing limb publication-title: Dev Dyn doi: 10.1002/dvdy.1212 contributor: fullname: Yin – volume: 238 start-page: 265 year: 1998 ident: 2021122705121417400_R1 article-title: In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells publication-title: Exp Cell Res doi: 10.1006/excr.1997.3858 contributor: fullname: Johnstone – volume: 48 start-page: 1315 year: 2003 ident: 2021122705121417400_R24 article-title: Plasticity of clonal populations of dedifferentiated adult human articular chondrocytes publication-title: Arthritis Rheum doi: 10.1002/art.10950 contributor: fullname: Barbero – volume: 37 start-page: 313 year: 2005 ident: 2021122705121417400_R41 article-title: Hypoxia induces chondrocyte-specific gene expression in mesenchymal cells in association with transcriptional activation of Sox9 publication-title: Bone doi: 10.1016/j.bone.2005.04.040 contributor: fullname: Robins – volume: 160 start-page: 285 year: 2015 ident: 2021122705121417400_R10 article-title: Identification and specification of the mouse skeletal stem cell publication-title: Cell doi: 10.1016/j.cell.2014.12.002 contributor: fullname: Chan – volume: 10 start-page: 676 year: 2008 ident: 2021122705121417400_R18 article-title: Isolation of human mesenchymal stromal cells is more efficient by red blood cell lysis publication-title: Cytotherapy doi: 10.1080/14653240802398845 contributor: fullname: Horn – volume: 60 start-page: 1390 year: 2009 ident: 2021122705121417400_R14 article-title: Cartilage repair in a rat model of osteoarthritis through intraarticular transplantation of muscle-derived stem cells expressing bone morphogenetic protein 4 and soluble Flt-1 publication-title: Arthritis Rheum doi: 10.1002/art.24443 contributor: fullname: Matsumoto – volume: 21 start-page: 1627 year: 2013 ident: 2021122705121417400_R44 article-title: Basic science and clinical application of platelet-rich plasma for cartilage defects and osteoarthritis: a review publication-title: Osteoarthritis Cartilage doi: 10.1016/j.joca.2013.07.017 contributor: fullname: Zhu – volume: 198 start-page: 1 year: 2015 ident: 2021122705121417400_R42 article-title: TGF-β2 is involved in the preservation of the chondrocyte phenotype under hypoxic conditions publication-title: Ann Anat doi: 10.1016/j.aanat.2014.11.003 contributor: fullname: Das – volume: 5 start-page: 623 year: 1999 ident: 2021122705121417400_R8 article-title: VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation publication-title: Nat Med doi: 10.1038/9467 contributor: fullname: Gerber – start-page: 294 issue: 151 year: 1980 ident: 2021122705121417400_R5 article-title: Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo publication-title: Clin Orthop Relat Res contributor: fullname: Ashton – volume: 105 start-page: 10185 year: 2008 ident: 2021122705121417400_R21 article-title: Soluble receptor-mediated selective inhibition of VEGFR and PDGFRbeta signaling during physiologic and tumor angiogenesis publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0803194105 contributor: fullname: Kuhnert – volume: 111 start-page: 13954 year: 2014 ident: 2021122705121417400_R40 article-title: Metabolic programming of mesenchymal stromal cells by oxygen tension directs chondrogenic cell fate publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1410977111 contributor: fullname: Leijten – volume: 44 start-page: 1608 year: 2001 ident: 2021122705121417400_R50 article-title: Molecular markers predictive of the capacity of expanded human articular chondrocytes to form stable cartilage in vivo publication-title: Arthritis Rheum doi: 10.1002/1529-0131(200107)44:7<1608::AID-ART284>3.0.CO;2-T contributor: fullname: Dell’Accio – volume: 19 start-page: 1960 year: 2013 ident: 2021122705121417400_R28 article-title: Scaffold-based delivery of a clinically relevant anti-angiogenic drug promotes the formation of in vivo stable cartilage publication-title: Tissue Eng Part A doi: 10.1089/ten.tea.2012.0455 contributor: fullname: Centola – volume: 64 start-page: 384 year: 2002 ident: 2021122705121417400_R29 article-title: In vitro expression of the endothelial phenotype: Comparative study of primary isolated cells and cell lines, including the novel cell line HPMEC-ST1.6R publication-title: Microvasc Res doi: 10.1006/mvre.2002.2434 contributor: fullname: Unger – volume: 113 start-page: 188 year: 2004 ident: 2021122705121417400_R36 article-title: Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival publication-title: J Clin Invest doi: 10.1172/JCI200419383 contributor: fullname: Maes – volume: 327 start-page: 580 year: 2010 ident: 2021122705121417400_R45 article-title: Platelets amplify inflammation in arthritis via collagen-dependent microparticle production publication-title: Science doi: 10.1126/science.1181928 contributor: fullname: Boilard – volume: 335 start-page: 793 year: 2005 ident: 2021122705121417400_R48 article-title: Vascular endothelial growth factor receptors in osteoclast differentiation and function publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2005.07.145 contributor: fullname: Aldridge – volume: 16 start-page: 718 year: 2008 ident: 2021122705121417400_R52 article-title: Physiological promoters reduce the genotoxic risk of integrating gene vectors publication-title: Mol Ther doi: 10.1038/mt.2008.5 contributor: fullname: Zychlinski – volume: 32 start-page: 8150 year: 2011 ident: 2021122705121417400_R30 article-title: Scaffold vascularization in vivo driven by primary human osteoblasts in concert with host inflammatory cells publication-title: Biomaterials doi: 10.1016/j.biomaterials.2011.07.041 contributor: fullname: Ghanaati – volume: 23 start-page: 267 year: 2004 ident: 2021122705121417400_R34 article-title: Endostatin/collagen XVIII--an inhibitor of angiogenesis--is expressed in cartilage and fibrocartilage publication-title: Matrix Biol doi: 10.1016/j.matbio.2004.06.003 contributor: fullname: Pufe |
SSID | ssj0000696920 |
Score | 2.329845 |
Snippet | This study assessed whether simple inhibition of angiogenesis by vascular endothelial growth factor (VEGF) blockade is sufficient to direct in vivo... : Chondrogenic differentiation of bone marrow-derived mesenchymal stromal/stem cells (MSCs) can be induced by presenting morphogenetic factors or soluble... Abstract Chondrogenic differentiation of bone marrow-derived mesenchymal stromal/stem cells (MSCs) can be induced by presenting morphogenetic factors or... |
SourceID | pubmedcentral proquest crossref pubmed wiley |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 1730 |
SubjectTerms | Adult Angiogenesis Bone marrow Bone Marrow Cells - cytology Bone Marrow Cells - drug effects Bone Marrow Cells - metabolism Cartilage Cell Differentiation - drug effects Cell Proliferation - drug effects Chondrogenesis Chondrogenesis - drug effects Data analysis Endothelial Cells - cytology Endothelial Cells - drug effects Endothelial Cells - metabolism Enzymes Female Humans Hypertrophy Hypoxia Laboratory animals Male Mesenchymal Stromal Cells - cytology Mesenchymal Stromal Cells - drug effects Mesenchymal Stromal Cells - metabolism Mesenchymal stromal/stem cells Mesenchyme Neovascularization, Physiologic - drug effects Osteoprogenitor cells Oxygen - pharmacology Phenotypes Progenitor cells Signal Transduction - drug effects Stem cell transplantation Stem cells Tissue Engineering and Regenerative Medicine Transduction, Genetic Transforming Growth Factor beta - metabolism Vascular endothelial growth factor Vascular Endothelial Growth Factor A - metabolism Vascular endothelial growth factor blockade Vascular Endothelial Growth Factor Receptor-2 - metabolism Young Adult |
SummonAdditionalLinks | – databaseName: AUTh Library subscriptions: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9NAEF6V9sIFgXi5FLRISJxW8a73YZ9QkyYEpFYVaaveLGcfSaRgh8ZU6q_oX-6M7QSiSnD2el8zu_PN7DwI-TTVNmRpUMwlsWUy-JQVhREskzJYm6RetQ6yZ3p8Kb9fq-s9Mt7EwqBb5eZObC5qV1m0kfcEaAZap4kUvWKKVgBb976sfjGsH4XvrF0xjSfkQHCJD7YH_eHZ-Y-tvSXWmc6aLI0g5AwDGCPbHI4Kuu2tbY1h6VyxOBF8V0Y9Ap6P_Sf_xrWNYBo9J886REmPWxZ4QfZ8-ZLcT1ZVCbjPg2JPv5X0anFb0cG8wvQEM7zeFmtaBdqvSk9PmzyM7AR48dY7eorxSHZ-9xM6PW9aw6G_oQO_XK7p9I72QfyhfZ1edU6sdFg6jONaAivTr9BVPaejpowPnSxmCPTL2StyORpeDMasq73ArDRxzCxHA6E2BehrRmcu5VYBVOMq-DgLjjsVnHCgGwKCsEVmdZyGxAblQuGs5kXymuyXsIa3hPoQDBcGoIezEngm02kQhUhkKoXRhYjI581u56s2xUYOqgnSJUe65EiXHOkSkaMNMfLuqK3zP4wRkY_bz3BI8OWj3ecclSgjsNpaRN60tNsOBWo5TF7B32aHqtsGmIB790u5mDeJuBWHoaWMiGzo_5_Z55PBRSIwfIyDHpjEh_9ezTvyFBu3rjNHZL---e3fAwCqpx863n4A-s8GsA priority: 102 providerName: ProQuest – databaseName: Wiley-Blackwell Open Access Collection dbid: 24P link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbhMxELZQuXBBoBYIlMqVkDhZrL3-22MbGgpSUaW0VW_Wxj9JpLBbNaFSb30EeEWehBlvumrUAxLHlddjr2fG_mbWM0PIh4n2qbJJsVAWnskULatrI1glZfK-tFF1F2S_6-Nz-e1SXT6I4u_yQ_QON9SMvF-jgteTXIVEAULPZQlXGEnOFStKjCR_CtjGolwLedp7WQpd6SrnZoSjzTAAL7LL3IhEPm2S2DyZHsHNx7cmH6LZfByNXpDnaxxJDzrGvyRPYrNNfo-v2gbQXgRznn5t6MX8pqXDWYtJCaa4qc2XtE30sG0iPcnZF__c_foMMngTAz3BOCQ_u_0BZE_z-6Ds13QYF4slndzSQzj20K9OL9aXV-lREzB-awEiTL8AsdWMjnL5HjqeTxHgN9Mdcj46Ohses3XNBealKQrmOToGtanBTjO6CpZ7BRCNqxSLKgUeVAoigE0IyMHXldeFTaVPKqQ6eM3r8hXZauAr3hAaUzJcGIAcwUuQlUrbJGpRSiuF0bUYkI_36-2uutQaDkwS5IxDzjjkjEPODMjuPTvcWsWWToCpqLUtJRDa75tBOfCPR7fSDo0nI7DK2oC87rjXDwXmOExeQW-zwdf-BUy8vdnSzGc5AbfiMLSUAyKzBPxj9m48PCsFho1xsP_K4u3_dXtHnuFTd5Vml2ytrn_G9wCIVpO9LPN_AQzTB5k priority: 102 providerName: Wiley-Blackwell |
Title | Spontaneous In Vivo Chondrogenesis of Bone Marrow‐Derived Mesenchymal Progenitor Cells by Blocking Vascular Endothelial Growth Factor Signaling |
URI | https://onlinelibrary.wiley.com/doi/abs/10.5966%2Fsctm.2015-0321 https://www.ncbi.nlm.nih.gov/pubmed/27460852 https://www.proquest.com/docview/2289668342/abstract/ https://search.proquest.com/docview/1826724417 https://pubmed.ncbi.nlm.nih.gov/PMC5189644 |
Volume | 5 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pa9swFBZNd9llbOyXuy5oMNhJja2f9nHxknWDlLC0JTfjSFZiSOzQZIX-FfuX9yTboaGHwS6-yEi2vie_75Pfe0Lo80Jqm8RWEMNCTbgtYpLnipKEc6s1iwvRBMheycsb_nMu5idIdLkwPmhfL8qLar25qMqVj63cbvSgixMbTCepiOIE_Pigh3qKsUcSvfn8JjLx5RjBmykCfIU3xRoFMPvBTu9d_nkkSMioOyYGVJkE2kGP_dITsvk0ZvIxl_XOaPwSvWhZJP7aPO0rdFJUr9Gf2baugOsVIObxjwrflvc1Tle1K0mwdJ-0codri4d1VeCJr71IvoH93RcGT1wOkl49bKDTqb8bFvodTov1eocXD3gILs_tqePbNnAVjyrjcrfWYL74O3S1X-GxP7oHz8qlI_fV8g26GY-u00vSnrdANFdhSHTkNgWlykGjKZmYONIC6FkkbBEm1kRGWEMN6EFgDTpPNMybZdoKY3OjZZSzt-i0gnd4j3BhrYqoArphNAc7SWRsaU4ZjzlVMqcB-tLNdrZtympkIEccRJmDKHMQZQ6iAJ13YGTt8tplFGSilDHj0NGnQzMsDPe3o5nnzAknRd0JawF612B3GKoDPUDqCNXDDa7o9nEL2KIvvt3aXoC4x_8fT5_N0mtGXcpYBNqPhWf_PeAH9Nz100TSnKPT_d3v4iPwof2ij3qUT-Gq5qqPng1HV9Nffb-30Pcr4y_kyA7S |
link.rule.ids | 230,315,733,786,790,870,891,11589,12083,21416,27957,27958,31754,31755,33779,33780,43345,43840,46087,46511,50849,50958,53827,53829,74102,74659 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9NAEF5BOcAFgXgZCiwSEqdV7X3ap4qGhhSaCilplZvl7COJlNqhTiv1V_CXmbGdQFQJzvv2N7v7zXh2hpCPU21DlgbFnIgtk8GnrCgMZ5mUwVqRetU6yJ7pwbn8NlGTzuBWd26VmzOxOahdZdFGfsBBM9A6FZIfrn4yzBqFf1e7FBr3yQMphESXPjMxWxtLrDOdNZEZ4WIzDKiLbOM2KujqoLZrfIqeKBYLnuzeS3fI5l2fyb-5bHMZ9Z-Qxx2LpJ9b2J-Se758Rn6NVlUJXM-DMk9PSnqxuKlob15hSIIZHmmLmlaBHlWlp8Mm9iL7AvJ34x0d4hskO7-9hE5_NLVho1_Rnl8uazq9pUdw5aFNnV50jqv0uHT4dmsJ4ku_QlfrOe03qXvoaDFDcl_OnpPz_vG4N2BdvgVmpYljZhM0CmpTgI5mdObSxCqgZ4kKPs6CS5wKjjvQB4E12CKzOk6DsEG5UDirk0K8IHslrOEVoT4Ek3ADdMNZCXKS6TTwgguZSm50wSPyafO181UbViMHdQRxyRGXHHHJEZeI7G_AyLvtVed_hCEiH7bFsDHwb0f7nXNUnAzHDGsRedlitx0KVHGYvILWZgfVbQUMur1bUi7mTfBtlcDQUkZENvj_Z_b5qDcWHJ-MJaD7ifj1v1fznjwcjIen-enJ2fc35BE2bF1n9sne-uravwUCtJ6-a6T8N5A5BH0 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LbxMxELagSIgLAvFaWsBISJysrL1-7J4QTRtaoFWltFVu1saPJFLYDU1aqb-Cv8zM7iYQVYKz356x55vxeIaQD2PtYpFHxXyWOiZjyFlZGsEKKaNzWR5U6yB7qo8u5NeRGnX-T8vOrXJ9JzYXta8d2sh7AjQDrfNMil7s3CLODgafFj8ZZpDCl9YuncZ98gCkZIrZDMzIbOwtqS500URpBCFnGMAY2cZwVNBtb-lW-C2dK5Zmgm_LqDvA867_5N-4thFMgyfkcYco6eeWBZ6Se6F6Rn4NF3UFuC-AYk-PK3o5u6lpf1pjeIIJXm-zJa0j3a-rQE-aOIzsAHjxJnh6gv-R3PT2B3R61tSGQ39F-2E-X9LxLd0H8Yf2dXrZObHSw8rjP645sDL9Al2tpnTQpPGhw9kEgX41eU4uBofn_SPW5V5gTpo0ZY6jgVCbEvQ1owufc6cAqnEVQ1pEz72KXnjQDQFBuLJwOs1j5qLysfRO8zJ7QXYqWMMrQkOMhgsD0MM7CTxT6DyKUmQyl8LoUiTk43q37aINsWFBNUG6WKSLRbpYpEtC9tbEsN1RW9o_jJGQ95tiOCT48tHus0UlygjMtpaQly3tNkOBWg6TV9DabFF1UwEDcG-XVLNpE4hbcRhayoTIhv7_mb0d9s8zgd_HOOiBWfr636t5Rx4Cg9vvx6ffdskjbNd60eyRndXVdXgDWGg1ftsw-W-ppgip |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Spontaneous+In+Vivo+Chondrogenesis+of+Bone+Marrow-Derived+Mesenchymal+Progenitor+Cells+by+Blocking+Vascular+Endothelial+Growth+Factor+Signaling&rft.jtitle=Stem+cells+translational+medicine&rft.au=Marsano%2C+Anna&rft.au=Medeiros+da+Cunha%2C+Carolina+M.&rft.au=Ghanaati%2C+Shahram&rft.au=Gueven%2C+Sinan&rft.date=2016-12-01&rft.issn=2157-6564&rft.eissn=2157-6580&rft.volume=5&rft.issue=12&rft.spage=1730&rft.epage=1738&rft_id=info:doi/10.5966%2Fsctm.2015-0321&rft.externalDBID=n%2Fa&rft.externalDocID=10_5966_sctm_2015_0321 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2157-6564&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2157-6564&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2157-6564&client=summon |